NDC 50242-132

Herceptin

Trastuzumab

Herceptin is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Genentech, Inc.. The primary component is Trastuzumab.

Product ID50242-132_23b49e45-e152-40c5-bbc9-be52fce667af
NDC50242-132
Product TypeHuman Prescription Drug
Proprietary NameHerceptin
Generic NameTrastuzumab
Dosage FormInjection, Powder, Lyophilized, For Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date2017-02-10
Marketing CategoryBLA / BLA
Application NumberBLA103792
Labeler NameGenentech, Inc.
Substance NameTRASTUZUMAB
Active Ingredient Strength150 mg/7.4mL
Pharm ClassesHER2/neu Receptor Antagonist [EPC],HER2/Neu/cerbB2 Antagonists [MoA]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 50242-132-01

1 VIAL, SINGLE-DOSE in 1 CARTON (50242-132-01) > 15 mL in 1 VIAL, SINGLE-DOSE
Marketing Start Date2017-02-10
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 50242-132-10 [50242013210]

Herceptin INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Marketing CategoryBLA
Application NumberBLA103792
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2019-06-03

NDC 50242-132-01 [50242013201]

Herceptin INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Marketing CategoryBLA
Application NumberBLA103792
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2017-02-10

Drug Details

Active Ingredients

IngredientStrength
TRASTUZUMAB150 mg/7.4mL

OpenFDA Data

SPL SET ID:492dbdb2-077e-4064-bff3-372d6af0a7a2
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1922509
  • 1922518
  • 1922512
  • 1922516
  • 806573
  • 806575
  • Pharmacological Class

    • HER2/neu Receptor Antagonist [EPC]
    • HER2/Neu/cerbB2 Antagonists [MoA]

    NDC Crossover Matching brand name "Herceptin" or generic name "Trastuzumab"

    NDCBrand NameGeneric Name
    50242-132HerceptinTrastuzumab
    50242-134HerceptinTrastuzumab
    50242-333HerceptinTrastuzumab
    63459-303HERZUMATRASTUZUMAB
    63459-305HERZUMATRASTUZUMAB
    67457-845OGIVRItrastuzumab
    67457-847OGIVRItrastuzumab
    67457-991OGIVRItrastuzumab
    0006-5033Ontruzanttrastuzumab
    0069-0305Trazimera-qyyptrastuzumab

    Trademark Results [Herceptin]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    HERCEPTIN
    HERCEPTIN
    74733146 2157198 Live/Registered
    GENENTECH, INC.
    1995-09-22

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.